Ghrelin o-acyl transferase (GOAT) inhibitors for use in the treatment of substance use disorder in patients with high impulsivity
TW202633628APending Publication Date: 2026-08-16BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114136469
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-24
- Filing Date
- 2025-09-23
- Publication Date
- 2026-08-16
Abstract
which are ghrelin O-acyl transferase (GOAT) inhibitors for use in the treatment of substance use disorder (SUD,) in particular for use in the treatment of opioid use disorder (OUD) or stimulant use disorder (StimUD), in patients with high impulsivity.
Need to check novelty before this filing date? Find Prior Art